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Abstract - Infections associated with medical procedures, or hospital-acquired infections (HAIs), occur in all hospitals 
worldwide. An integrated infection-control program with HAI surveillance as its cornerstone can reduce the incidence 
of HAIs and contribute to economic benefits. The aim of this paper was to report the prevalence and epidemiological 
features of HAI in hospitals in Vojvodina, Serbia. The study population examined herein was compromised of all of the 
patients present in the ward at least 48 hours before the day of surveillance. It also included patients that were scheduled 
for discharge or transfer, and those temporarily absent from the ward for examinations or diagnostic procedures. Data 
were collected using uniform questionnaires, created by the scientific board of the study. Data from paper questionnaires 
were entered into a specially created electronic database and analyzed using standard statistical methods. A total of 2 435 
patients were included in the study. The frequency of patients with HAI was 6.6% (95% CI: 5.6%-7.6%), and the prevalence 
of infection was 7.1% (95% CI: 6.1%-8.1%). HAI prevalence was significantly different depending on the ward, ranging 
from 1.7% in the gynecology department to 18.1% in intensive care departments. The most common type of HAI was 
pneumonia, representing 20.9% of all reported HAIs. The second most frequently reported type of HAI was surgical 
site infection (19.8%), followed by urinary tract infection (17.4%), gastro-intestinal infection (14.5%) and bloodstream 
infection (11.0%). The most commonly found microorganisms were Enterococcus spp. (14.5%), Klebsiella pneumoniae 
(14.5%), Acinetobacter spp. (13.7%), coagulase-negative Staphylococcus spp. (12.1%), Pseudomonas aeruginosa (10.5%) 
and Clostridium difficile (7.3%). The most frequently used antibiotics in therapy were third generation cephalosporins to 
which most of the isolates showed resistance. Although the consumption of carbapenems in this sample was only 8%, the 
registered carbapenem resistance in some bacteria indicates more frequent and longer use of carbapenems in hospitals 
with the side effect of selective pressure.
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INTRODUCTION
Hospital-acquired  infections  (HAIs)  are  a  major 
worldwide public health problem dating back to the 
first hospitals, and it remains important today. It is 
well known that HAIs have been associated with sig-
nificant morbidity and attributable mortality, as well 
as greatly increased healthcare costs (Rosenthal et 
al., 2008).
Studies conducted in the United States more than 
30 years ago and recently validated in Germany have 524 GORANA ĆOSIĆ ET AL.
shown that an integrated infection-control program 
with HAI surveillance as its cornerstone can reduce 
the incidence of HAIs by 30%, yielding economic 
benefits (Haley et al., 1980; Gastmeier et al., 2006).
Surveillance of HAIs is an important component 
of comprehensive infection prevention and control 
programs  (Haley  et  al.,  1985).  The  gold  standard 
for  epidemiological  surveillance  is  prospective  ac-
tive  surveillance.  Point  prevalence  surveys  (PPS), 
although not as accurate as the traditional prospec-
tive method, provide baseline information about the 
occurrence and distribution of HAIs within a health-
care institution and help to establish priorities for in-
fection prevention and control departments.
Repeated  prevalence  surveys  have  been  used 
for the evaluation of infection control programs, for 
intra-hospital comparisons, to follow trends in HAI 
rates,  to  determine  rates  of  device  utilization  and 
antibiotic usage, and to measure adverse effects and 
costs associated with these infections (French et al., 
1989; Weinstein et al., 1999; Sax et al., 2001; French 
et al., 1991). 
During an expert meeting held in Brussels in No-
vember 2010, it was recommended that PPSs of HAIs 
and antimicrobial use should be carried out at least 
once every five years, and the patient-based protocol 
was selected as the preferred methodology for future 
PPSs  (Goossens  et  al.,  2011).  The  first  prevalence 
study of hospital infections in Serbia was conducted 
in 1999, the second in 2005 and the third in 2010 
(Marković-Denić et al., 2000, 2007, 2010).
This  paper  presents  data  obtained  during  the 
third national prevalence survey of the prevalence 
of HAIs and their general epidemiological features 
in the Autonomous Province of Vojvodina (APV), 
northern Serbia. The aim was to identify the most 
common localization and prevalence of HAIs in dif-
ferent departments, to consider the most common 
risk factors, the most frequent microbiological agents 
of HAIs, as well as their resistance to antibiotics, and 
to determine patterns of antimicrobial use.
MATERIALS AND METHODS
The point prevalence study was carried out in No-
vember 2010 in 12 hospitals in the APV. It included 
8  general  hospitals  (secondary  level),  5  university 
hospitals (tertiary level) and 4 specialized institutes. 
Patients hospitalized in the internal medicine, sur-
gery, obstetric and gynecology, pediatrics and inten-
sive care departments, at least 48 hours before the 
day of surveillance (including those scheduled for 
discharge or transfer, and those temporarily absent 
from the ward for examinations or diagnostic proce-
dures) were included.
All patients with acute infection on the day of 
study were registered as patients with HAI except 
those who already had an infection or were in the 
incubation period on the day of admission. Several 
infections of different anatomic localization in the 
same patient were registered as separate (other) in-
fections. National definitions and criteria based on 
US CDC definitions were used to set up diagnosis of 
HAIs (Drndarević et al., 1998).
Trained  medical  staff  completed  the  question-
naires for each patient with data collected from clini-
cal records, temperature charts, laboratory reports, 
and information provided by physicians and nurses 
in each ward. Study variables included demograph-
ics (sex, age), primary diagnosis (primary diagnos-
tic group: diseases of circulatory system, neoplasms, 
diseases of genitourinary, respiratory, musculoskel-
etal and central nervous system, infectious diseases, 
and the newborn), comorbidities (diabetes, arterial 
hypertension, trauma), and factors related to health 
care, including surgery procedures, mechanical ven-
tilation, central and peripheral venous catheter, uri-
nary catheter, and the use of antimicrobials. Infor-
mation on variables associated with surgery (type of 
surgical site, duration of surgery, antibiotic prophy-
laxis) was also collected. Microbiological data were 
recorded as microorganisms identified in cultures, 
as well as antimicrobial sensitivity tests. In cases of 
material for microbiological examination taken on 
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able, microbiological analyses were collected within 
the next 72 hours.
Data  were  collected  by  the  uniform  question-
naire according to the protocol created by the sci-
entific board of the study and the National Expert 
Committee  for  HAIs  (www.batut.org.sr),  offering 
detailed instructions to pollsters for the registration 
and classification of hospital infections. 
Hospital personnel dedicated to collect data were 
educated in the first phase of the study and in the 
phase  of  study  implementation  were  coordinated 
by epidemiologists from the regional Public Health 
Institutes. Final evaluation of data from all hospitals 
in the province was done at the Institute of Public 
Health of Vojvodina.
Statistical analysis was performed using the Sta-
tistical Package for Social Sciences Software (SPSS 
Inc, version 7.50, Chicago, IL). The results were ex-
pressed as the mean ± SD or as a proportion of the 
total number of patients. Relations between categori-
cal variables and NI were first evaluated using con-
tingency table analysis and χ² test or Fisher’s Exact 
Probability  Test  and  univariate  logistic  regression 
analysis. The Student’s t-test was used for comparison 
of parametric continuous variables. The odds ratios 
(OR) and corresponding 95% confidence intervals 
were computed for overall site infection rate.
RESULTS
A total of 2 435 patients were included in the study. 
The mean age of the patients was 54.7 ± years (rang-
ing from 3 days to 94 years). The male-female ratio 
was 1:1.1. 
There were 1 162 (47.7%) patients on medical 
units, 652 (26.8%) on surgical units, 280 (11.5%) on 
gynecology units, 214 (8.8%) on pediatric units and 
127 (5.2%) in critical care units. 
Overall, 6.6% patients had at least one HAI, rang-
ing from 1.7% in gynecology departments, to 18.1% 
in  intensive  care  departments  (Table  1).  The  HAI 
prevalence was significantly different depending on 
ward type (χ2 = 111.762, P = 0.0000).
The prevalence of HAIs was 6.2% in general hos-
pitals, 6.3% in institute hospitals and 8.1% in clini-
cal centers. There were no statistically differences in 
HAI prevalence and hospital types (χ2 = 0.836, P(χ2 > 
0.836) = 0.3605).
On the day of the survey, 160 patients had a total 
of 172 HAIs. Thus, the prevalence of patients with 
HAI was 6.6 % (95% CI: 5.6-7.6%) and the preva-
lence of infection was 7.1% (95% CI: 6.1-8.1%). On 
average, there were 1.1 HAIs per infected patient (or 
a total of 172 HAIs in 160 patients with HAI). Twelve 
patients (0.5%) had two HAIs.
The  epidemiological  characteristics  of  the 
patients, medical devices and interventions pro-
vided to the patients and their association with 
HAIs are shown in Table 1. 
The  most  common  devices  used  were  periph-
eral catheters (46.2% of patients) and urinary cath-
eters (24.0% of patients) which were either in situ or 
present within the seven days before the survey was 
conducted. Mechanical ventilation and nasogastric 
sonde were less frequently applied but showed a sig-
nificant association with HAIs. Relative risk for the 
development of pneumonia was significantly higher 
for  patients  with  mechanical  ventilation  and  na-
sogastric sonde (P <0.0001).
The  epidemiological  variables  with  significant 
association with HAIs after univariate analysis indi-
cated that 7 (36.8%) of the 19 bloodstream infections 
(BSI) were central venous catheter- related and 10 
(27.7%)  of  the  36  pneumonias  were  ventilator-as-
sociated. The relative risk for development of pneu-
monia or BSI was statistically significant for patients 
with invasive devices (p< 0.0001). 
Table 2 shows the distribution of HAIs by type 
and anatomical site. The most common type of HAI 
was pneumonia, representing 20.9% of all HAIs. The 
second most frequently registered type of HAI was 526 GORANA ĆOSIĆ ET AL.
Table 1. Epidemiological variable in patients with and without hospital-acquired infection (univariate analysis), Vojvodina, Serbia, 
2010.
Variable
Number of 
Patients
% Patients with HAI
Prevalence of HAI
(%)
Patients without 
HAI, 
p value
Mean age  2 435 100
Sex – male/female  2 435 100
Hospitalized in Internal medicine  1 162 47.7 60 5.2
Hospitalized in Gynecology 652 26.8 11 1.7
Hospitalized in Surgery 280 11.5 49 17.5
Hospitalized in Pediatrics 214 8.8 17 7.9
Intensive care unit 127 5.2 23 18.1
Infection on admission - YES 680 27.9 49 7.2 631 0.620, 0.4311
Immunosuppression- YES 149 6.1 16
25.910,
0.0000
Peripheral intravenous catheter- YES 1126 46.2 105/110
25.881
0.0000
Central intravenous catheter- YES 107 4.4 25/32HAI/7 BSI
51.415
0.0000
Mechanically ventilated- YES 46 1.9 10 PN RR
Nasogastric sonde- YES 65 2.7 13 PN RR
Urinary indwelling catheter within the 
previous seven days - YES
587 24.1 7UTI
12.610
0.0004
Stay in intensive care unit >1day
Average length of stay in intensive care 
unit (days)
? 8.4 ±
71.380
0.0000
Surgical treatment - YES (N=2435) 629 25.8 61 (32 SSI)
18.139
0.0000
Surgical drains - YES 
(n=2435)
147 23.4 18
8.204
0.0042
Endoscopic procedures  - YES 50 7.9 3 (1 SSI)
ASA score (in operated patients N=629) 629 100
ASA score 1 and 2 (in operated patients 
N= 629)
304 48.3 21 (14 SSI)
0.616
0.4327
ASA  score >=3 (in operated patients 
N= 629)
298 47,4 39 (18 SSI)
ASA score unknown (in operated 
patients N= 629)
27 4,3 1 (0 SSI)
Wound classification (in operated 
patients N= 629)
629 100
Clean 350 55.6 9 SSI
Clean/contaminated 163 25.9 10 SSI
Contaminated 77 12.2 9 SSI
Dirty 39 6.2 4 SSI
Surgical drains (in operated patients 
n= 629)
129 2.5
Average duration of surgery among 
operated N=629, (min)
629 94.4 ±
Average length of stay in intensive care 
(days) for surgery patients
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surgical site infection (19.8%), followed by urinary 
tract  infection  (17.4%),  gastro-intestinal  infection 
(14.5%)  and  bloodstream  infection  (11.0%).  Gas-
trointestinal infection caused by Clostridium difficile 
represented 5.2% of all HAIs.
Microbiology
72.1% of the HAIs (124/172) were documented by 
microbiological results. The total number of isolates 
was 124 and total number of microorganisms 25. The 
most commonly isolated groups of microorganisms 
were equally Gram-positive cocci and Enterobacte-
riaceae (33.9% each) (Table 3). 
The  most  commonly  found  micro-  organisms 
were Enterococcus spp. (14.5%), Klebsiella pneumo-
niae (14.5%), Acinetobacter spp. (13.7%), coagulase-
Table 2. Prevalence and relative percentage of healthcare-associated infection by type of infection, Vojvodina Province, Serbia, 2010. 
Type of infection
HAIs Prevalence of HAIs (%)
N=2435
95 CI (%)
Nbr. % 
Surgical site infection 34 19.8
1.4
5.4*
0.93-1.87
Urinary tract infection 30 17.4 1.2 0.77-1.63
Pneumonia 36 20.9 1.5 1.02-1.98
Bloodstream infection (BSI) 19 11.0 0.8 0.45-1.15
Bone or joint infection 0 0.0 0.0
Cardiovascular system infection 1 0.6 0.0
Central nervous system infection 0 0.0 0.0
Eye, ear, nose or mouth infection 1 0.6 0.0
Gastrointestinal infection 25 14.5 1.0 0.60-1.40
Lower respiratory tract infection 11 6.4 0.5 0.22-0.78
Reproductive tract infection 1 0.6 0.0 0.0- 0.0%
Skin and soft tissue infection 8 4.7 0.3 0.08-0.52
Systemic infection 6 3.5 0.2 0.02-0.38
Total 172 100.0 7.1 6.08- 8.12
*The denominator is 629 (patients that underwent surgery).
Table 3. Major groups of microorganisms, Vojvodina, Serbia, 2010.
Group of microorganisms
Isolates
N
%
Gram-positive cocci 42 33.9
Gram-negative - Enterobacteriaceae 42 33.9
Gram-negative bacteria - non fermentative 30 24.2
Gram-positive bacilli - Clostridium difficile 9 7.3
Candida albicans 1 0.8
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negative Staphylococcus spp. (12.1%), Pseudomonas 
aeruginosa (10.5%) and Clostridium difficile (7.3%).
Gram-negative organisms accounted for the ma-
jority of cases of pneumonia while most UTIs and 
BSIs were caused by Gram-positive cocci (staphylo-
cocci and enterococci). 
Microbiological examination results were avail-
able in 55.6% of PN, 55.8% of SSI, 84.2% of BSI and 
90% of UTI.
For 72.1% of the HAIs, a positive microbiology 
result was available. It revealed the presence of 36.0% 
gastro-intestinal  infections  and  90.0%  in  urinary 
tract infections (Table 5).
Table 4. Most prevalent species of microorganisms, Vojvodina, Serbia, 2010.
Most common types of microorganisms
Number of 
isolates
%
Acinetobacter spp. 17 13.7
Klebsiella pneumoniae 18 14.5
Pseudomonas aeruginosa 13 10.5
Citrobacter spp. 1 0.8
Clostridium difficile 9 7.3
Other Streptococcus spp. 1 0.8
Other 1 0.8
Enterobacter spp. 6 4.8
Enterococcus spp. 18 14.5
Escherichia coli 11 8.9
Proteus mirabilis 2 1.6
Staphylococcus aureus 6 4.8
Staphylococcus spp. coagulase-negative 15 12.1
Streptococcus pneumoniae 1 0.8
Candida albicans 1 0.8
Other Enterobacteriaceae 1 0.8
Morganella morganii 1 0.8
Proteus vulgaris 1 0.8
Streptococcus agalactiae (B) 1 0.8
Total 124 100.0
Table 5. Distribution of microorganisms isolated in healthcare-associated infections by main type of infection point prevalence survey 
in 2010 (n=124).
Pneumonia % SSI % UTI % BSI %
Acinetobacter spp 37.9 Enterobacter spp. 21.7 Enterococcus spp. 41.4
Staphylococcus spp. coag. 
neg
52.9
Pseudomonas aeruginosa 24.1 Staphylococcus aureus 17.4 Klebsiella pneumoniae 20.7    
Klebsiella pneumoniae 24.1 Enterococcus spp. 17.4 E. Coli 17.2    
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With  36%,  Clostridium  difficile  was  the  main 
pathogen causing gastrointestinal infections (infec-
tion prevalence 5.2%).
The percentage of methicillin-resistant S. aureus 
(MRSA) was 33.3% and that of glycopeptide-resist-
ant Enterococcus spp. 5.6%.
Carbapenem resistance was reported in 46.1% of 
Pseudomonas aeruginosa and 52.9% of Acinetobacter 
spp.
Antimicrobial use
At the time of the survey, 1 067 (43.8%) patients were 
receiving at least one antimicrobial agent, while 311 
(21.1%) were being treated with two drugs, 49 (4.6%) 
with three drugs and 6 (0.5%) with four drugs.
Of these, 326 (30.5%) patients were receiving at 
least one antimicrobial agent for prophylaxis and 714 
(66.9%) patients were receiving at least one antimi-
crobial agent for therapy indication.
Of those patients with an HAI, 92.5% were re-
ceiving at least one antibiotic at the time of survey.
The most frequently used drugs for prophylax-
is  were  cephalosporins  (58.6%),  aminoglycosides 
(11.6%) and derivatives of imidazole (9.4%).
The  most  commonly  prescribed  antimicrobial 
agents for therapy were cephalosporins (34.8%), com-
binations of penicillins with beta-lactamase inhibi-
tors (14.3%), fluoroquinolones (12.5%), aminogly-
cosides (12.1%) and derivatives of imidazole (8.8%); 
4.5% of the patients surveyed were on vancomycin.
The proportion of patients receiving antimicro-
bial treatment at the time of survey varied in different 
types of hospitals from 11.3% in institutes, to 47.5% 
in general hospitals (χ2 = 122.454. P(χ2 > 122.454) 
= 0.0000), and also varied in different departments 
(from 0.5% in pediatric department to 29.9% in in-
tensive care).
Table 6. Distribution of antimicrobial agents by main indication for use. Point prevalence survey 2010 (n= 1433 antimicrobial agents)
Antimicrobial agents in prophylaxis (%) Antimicrobial agents in therapy (%) Antimicrobial agents in HAI therapy (%)
Cephalosporins (58.6) Cephalosporins (34.8) Cephalosporins (28.3)
Aminoglycosides (11.6)
Combinations of penicillins with  
beta-lactamase inhibitors (14.3)
Combinations of penicillins with  
beta-lactamase inhibitors (13.1)
Derivatives of Imidazole (9.4) Fluoroquinolones (12.5) Derivatives of imidazole (12.7)
Fluoroquinolones (6.9) Aminoglycosides (12.1) Aminoglycosides (11.8)
Combinations of penicillins with beta-lacta-
mase inhibitors (6.7)
Derivatives of imidazole (8.8) Glycopeptides (11.0)
Table 7.
Types of hospital
Antibiotics used in prophylaxis 
(%)
Antibiotics used in therapy  
(%)
 Antibiotics used in HAI therapy 
(%)
Institute 11.3 29.1 23.6
Clinical center 41.2 15.7 24.3
General hospital 47.5 55.2 52.0
Total 100.0 100.0 100.0
Wards with the most common 
antibiotic use 
ICU and surgery department Pediatric department and ICU 530 GORANA ĆOSIĆ ET AL.
Table 8. Prevalence of healthcare-associated infections and antimicrobial use in surveyed patients, by specialty, during the point preva-
lence survey, 2010 (n=2435).
Specialty Surveyed patients Patients with HAI
Patients with antimicrobial 
use in therapy
N % N % N %
Internal medicine 1162 47.7 60 5.2 52 35.1
Gynecology 652 26.8 11 1.7 45 30.4
Surgery 280 11.5 49 17.5 11 7.4
Pediatrics 214 8.8 17 7.9 17 11.5
Intensive care 127 5.2 23 18.1 23 15.5
All specialties 2435 100 160 6.6 148 100.0
Among the patients with HAI, 148 (92.5%) were 
receiving at least one antibiotic for therapeutic pur-
poses. Two antibiotics were being given to 71 (44.4%) 
patients, three antibiotics to 16 (10%) and four anti-
biotics to 3 (1.8%) patients.
The  proportion  of  patients  with  antimicrobial 
treatment for therapy varied in different types of hos-
pitals from 15.7% in clinical centers to 55.2% in gen-
eral hospitals (χ2 = 22.615. P(χ2 > 22.615) = 0.0000). 
In addition, there were statistically significant differ-
ences between hospital departments, ranging from 
15.5% for gynecology to 53.7% for pediatric depart-
ments (χ2 = 116.481. P(χ2 > 116.481) = 0.0000).
DISCUSSION
Large multicenter prevalence surveys have been con-
ducted in Europe during the past decades and have 
shown  an  overall  prevalence  of  HAI  infections  of 
4-10 % (7.1%) (Gravel et al., 2007; Kampf et al., 1997; 
Emmerson et al., 1996; Scheel et al., 1998; Vaque et 
al., 1999; Pittet et al., 1999).
The range of reported prevalence results in stud-
ies that used CDC definitions for HAIs in non-EU 
countries ranged from 4.9% in Mauritius in 1992 to 
19.1% in Malaysia in 2001 (Allegranzi et al., 2011).
Such a range in the prevalence of HAIs could be 
explained by differences in methodology and patient 
case-mix, and should not immediately be interpreted 
as an indication of variations in performance (Zarb 
et al., 2012).
The first national prevalence study in Serbia was 
performed in 1999 in 27 hospitals; the second was 
done in 2005 in 56 hospitals and the third in 2010 
in 61 hospitals. The prevalence of patients with at 
least one HAI was 6.3%, 3.1% and 4.9%, respectively, 
and the HAI prevalence was 7.5%, 3.5% and 5.3%, 
respectively. 
Thus, the HAI prevalence of 7.1% (with 6.6% of 
patients infected) observed in our study is compara-
ble to that reported in other European studies (Lani-
ni et al., 2009; Struwe et al., 2006; The RAISIN Work-
ing Group, 2009) and to the European prevalence of 
HAIs of 7.1% estimated by ECDC based on a review 
of 30 national or multicenter PPSs in 19 countries in 
its Annual Epidemiological Report for 2008 (ECDC, 
2008).
The prevalence of HAI in this study is within the 
range reported by researchers from developing coun-
tries (Zarb et al., 2012; Lanini et al., 2009; Struwe et 
al., 2006).
However, it is very difficult to compare the prev-
alence studies and their results in different countries 
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medical  experience  and,  in  many  cases,  different 
methodologies (Marković-Denić, 2011).
The prevalence of HAIs and the prevalence of 
patients with HAIs in the results of our survey were 
little  higher  than  results  of  third  national  point 
prevalence study, but very similar to the results of a 
recently published pilot prevalence study in Europe 
(7.1% and 7.6%, respectively) (Zarb et al., 2012).
The occurrence of nosocomial infections differs 
in different hospitals and different wards, and in pa-
tients diagnosed differently. The highest prevalence 
rates of HAI were observed in intensive care units 
and surgery wards, similar to results of other studies 
(Gravel et al., 2007; Scheel and Stormark, 1998; Zarb 
et al., 2012; Struwe et al., 2006; van der Kooi et al., 
2010; Sánchez-Payá et al., 2009; Smyth et al., 2008; 
Eriksen et al., 2005) 
The  prevalence  of  HAI  in  critical  care  units 
(18.1%) or surgery departments (17.5%) was much 
higher than the overall prevalence of HAI (6.6%). 
This is an expected finding since the severity of ill-
ness and susceptibility to HAI in such units is by 
definition  higher  than  that  in  patients  in  general 
units.
Differences in infection rates between hospital 
wards can be explained by differences between pa-
tients,  patient  care,  operations  and  other  invasive 
procedures.
According to the results of previously conducted 
point prevalence studies, urinary tract infections are 
the leading health care-associated infection in devel-
oped countries, while in developing countries or in 
countries that have recently established HAI control 
programs, the most frequent type of HAI is surgical 
site infection (Pittet et al., 1999).
According to the results of the first national prev-
alence study in Serbia, the leading type of HAI was 
SSI, while in the second and third prevalence stud-
ies, the most frequent type of HAI was urinary tract 
infection. 
The most common type of HAI in our survey 
was pneumonia, representing 20.9% of all reported 
HAIs. Similar results were found in a recently pub-
lished pilot prevalence study of HAI in the EU (Zarb 
et al., 2012). 
The  following  patient  characteristics  were  sig-
nificantly  associated  with  pneumonia:  infections 
present at time of admission, immunosuppression 
and surgery procedures, stay in the ICU; having a na-
sogastric sonde or endotracheal tube and mechanical 
ventilation were also significantly associated with the 
development of pneumonia.
In our study, the use of devices was comparable 
with  the  results  of  other  recent  European  studies 
(Humphreys et al., 2008; Lyytikainen et al., 2008). 
The frequency of risk factors linked to medical 
services of patients with at least one risk factor is ex-
tremely high (69.3%). The risk factor analysis indi-
cated that the use of devices and procedures could be 
improved (urinary catheters, open surgical drains in 
approximately 20% of cases). 
In our study, the percentage of HAIs documented 
by microbiological results was similar to the results 
of the third national prevalence study (68.2%), but 
higher than results from some other studies (59.1% 
were recorded in a European point prevalence study, 
and 41.1% in a Lithuanian national study) (Zarb et 
al., 2012; Struwe et al., 2006).
According to the results of systematic review and 
meta–analysis, Gram-negative bacilli were the most 
common nosocomial isolates, both in mixed popula-
tion and in high-risk patients. More than half of the 
isolates in our survey belong to this group of micro-
organisms.
The  pathogens  predominantly  cultured  are 
known to be a major cause for HAIs. Overall, the 
most commonly isolated microorganisms were En-
terococcus  spp. (14.5%) and Klebsiella pneumoniae 
(14.5%),  followed  by  Acinetobacter  spp.  (13.7%), 
coagulase-negative Staphylococcus spp. (12.1%) and 532 GORANA ĆOSIĆ ET AL.
Table 9. 
Variable
Patients
N
%
Patients with  
HAI
Prevalence of 
HAI
(%)
Patients  
without HAI,  p value
Mean age  2435 100
Sex - male/female  2435 100
Hospitalized in Internal Medicine  1162 47.7 60 5.2
Hospitalized in Gynecology 652 26.8 11 1.7
Hospitalized in Surgery 280 11.5 49 17.5
Hospitalized in Pediatrics 214 8.8 17 7.9
Intensive Care Unit 127 5.2 23 18.1
Infection on admission - YES 680 27.9 49 7.2 631 0.620, 0.4311
Immunosuppression - YES 149 6.1 16
25.910,
0.0000
Peripheral intravenous catheter - YES 1126 46.2 105/110
25.881
0.0000
Central intravenous catheter - YES 107 4.4 25/32HAI/7 BSI
51.415
0.0000
Mechanically ventilated - YES 46 1.9 10 PN RR
Nasogastric sonde - YES 65 2.7 13 PN RR
Urinary indwelling catheter within the previous 
seven days - YES
587 24.1 7UTI
12.610
0.0004
Stay in intensive care unit >1day
Average length of stay in intensive care unit (days) ? 8.4 ±
71.380
0.0000
Surgical treatment - YES (N=2435) 629 25.8 61 (32 SSI)
18.139
0.0000
Surgical drains - YES 
(n=2435)
147 23.4 18
8.204
0.0042
Endoscopic procedures - YES 50 7.9 3 (1 SSI)
ASA score (in operated patients N=629) 629 100
ASA score 1 and 2 (in operated patients N= 629) 304 48.3 21 (14 SSI)
0.616
0.4327
ASA  score >=3 (in operated patients N= 629) 298 47,4 39 (18 SSI)
ASA score unknown (in operated patients N= 629) 27 4,3 1 (0 SSI)
Wound classification (in operated patients N= 629) 629 100
Clean 350 55.6 9 SSI
Clean/contaminated 163 25.9 10 SSI
Contaminated 77 12.2 9 SSI
Dirty 39 6.2 4 SSI
Surgical drains (in operated patients n= 629) 129 2.5
Average duration of surgery among operated N=629, 
(min)
629 94.4 ±
Average length of stay in intensive care (days) for 
surgery patients
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Pseudomonas  aeruginosa  (10.5%).  Similar  results 
were obtained in the third national point prevalence 
survey.
Some differences in results were reported regard-
ing the most common isolates of HAI in European 
studies, where the most common isolates were E. coli 
(15.2%) and Staphylococcus aureus (12.1%) (Zarb et 
al., 2012).
Carbapenem resistance was reported in 46.1% of 
Pseudomonas aeruginosa and 52.9% of Acinetobacter 
spp., which was much higher than the results of the 
third national prevalence survey (24.0% and 30.3%, 
respectively) and the results of some other studies 
(23.4% and 20.4%, respectively).
The percentage of methicillin-resistant S. aureus 
(MRSA) and that of glycopeptide-resistant Enterococ-
cus spp. was similar to results of the European point 
prevalence study (33% and 5.6%, respectively), but 
lower than results of the third national study (51% 
and 9%, respectively).
The overall prevalence of patients receiving an-
timicrobials in our survey was high (43.8%). This 
is consistent with results of the third national study 
(43.1%). Lower-use rates were found by a multi-cent-
er European study (29.6%), in Spain (33.8%), Lithua-
nia (26%), Canada (36.1%), the UK and the Republic 
of Ireland (33.1%), in the Netherlands (30.9%) and 
in Sweden (34.9%) (Zarb et al., 2012; Sánchez-Payá 
et al., 2009; Struwe et al., 2006; Gravel et al., 2007; 
Humphreys et al., 2008; van der Kooi et al., 2010; 
Reilly et al., 2008).
The highest percentage of antibiotic consumption 
in Vojvodina was registered in general hospitals, both 
for prophylaxis and for treatment of infections. Com-
pared with the results of European studies, the per-
centage of antibiotic use was also the highest in gen-
eral hospitals, but the percentage of use of antibiotics 
in relation to the type of hospital was fairly uniform 
from 36.2% in general hospitals to 35.7% in institutes 
(36.2%. 32.1% and 35.7%) (Zarb et al., 2012).
Antibiotic therapy for prophylaxis was the high-
est in intensive care and surgical wards, while for 
therapy, the highest use was in pediatric wards and 
in ICUs.
The most frequently used classes of antibiotics 
were similar to the results of the national prevalence 
study  and  some  other  studies  regarding  the  con-
sumption of cephalosporins, penicillins, quinolones 
and  imidazole  derivatives.  Aminoglycoside  use  in 
our hospitals was higher (12.1%) compared to the 
results of other studies (12.1% in ECDC and <2% 
in Canada). Cephalosporin use was also higher in 
comparison to the results of some studies (34.8% vs 
17.6%) (Zarb et al., 2012; Gravel et al., 2007).
Similar to results of other studies, the most fre-
quently  used  antibiotics  for  prophylaxis  were  ce-
phalosporins of the first and the second generation 
(77%),  while  for  therapy  third  generation  cepha-
losporins dominated (67%). 
CONCLUSION
The analysis of results presented herein has eluci-
dated some critical points for epidemiological inter-
vention. One was the high carbapenem resistance 
of Pseudomonas aeruginosa and Acinetobacter spp. 
Others were the high administration of antimicro-
bials. Due to this, intervention and development of 
policies aiming to reduce the use of antibiotics at 
both local and national levels is necessary. 
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